Wound Care Specialist Opening New Office at Harlingen Medical Center to Treat Diabetes, Other Patients with Foot Problems

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

HARLINGEN –  Dr. Luis R. Venegas, DPM, ABPM, a podiatrist, is opening a new office in Harlingen to treat patients with foot problems – including many diabetes patients in the Valley who may develop wounds on their feet which are difficult to heal.  At his new office, located at Harlingen Medical Center’s Medical Office Building, Dr. Venegas will look to increase access to foot care for patients in the Harlingen-San Benito area, and surrounding communities. 

Dr. Venegas has been seeing patients at the Wound Healing Center at Harlingen Medical Center for more than seven years now – as well as treating patients in the Brownsville area for the past 17 years.  During recent years, Dr. Venegas said he has been seeing more young patients in the Valley, including some in their 30’s and 40’s, developing foot wounds related to diabetes.  Dr. Venegas said that diabetic patients should check their feet every day, to look for lesions, ulcers or any other problems, which could lead to damage and dangerous infections of their feet. 

The public is invited to see Dr. Venegas’ new office and the Wound Healing Center during an open house on Wednesday, April 13, 2016, anytime between 3:30 p.m. and 5:30 p.m., in Harlingen Medical Center’s Medical Office Building, located at 5005 S. Expressway 77, Suite 101 and Suite 100 (in the building closest to the Expressway, outside the hospital, on the first floor).

- Advertisement -

In addition, the community can learn more about wound healing and ask questions to Dr. Venegas during a free “Doc Talk” that same evening, April 13, at 6 p.m. in Harlingen Medical Center’s conference room (also located in the HMC Medical Office Building, on the first floor, behind the elevators).  This event is being held as part of “National Foot Health Awareness Month” during the month of April. 

To RSVP for Dr. Venegas’ talk, which will include refreshments, please call (956) 365-1848.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -